Climb Bio, Inc.
CLYM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001768446
In the last 90 days, Climb Bio, Inc. insiders filed 0 open-market purchases and 2 sales; 108 institutions reported holding it in 13F filings for Q2 2026, worth $734.3M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Climb Bio, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- −13 vs. Q1 2022
- Shares held
- 15.1M
- −2.38M (−13.6%) vs. Q1 2022
- Total value
- $45.7M
- −$101.1M (−68.9%) vs. Q1 2022
- New holders
- 5
- 8 more added
- Sold out
- 18
- 14 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLYM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 108 | $734.3M |
| Q1 2026 | 80 | $221.2M |
| Q4 2025 | 65 | $157.4M |
| Q3 2025 | 68 | $89.7M |
| Q2 2025 | 69 | $61.9M |
| Q1 2025 | 76 | $63.4M |
| Q4 2024 | 80 | $100.3M |
| Q3 2024 | 71 | $278.2M |
| Q2 2024 | 47 | $354.8M |
| Q1 2024 | 21 | $46.2M |
| Q4 2023 | 23 | $45.5M |
| Q3 2023 | 23 | $44.0M |
| Q2 2023 | 22 | $46.8M |
| Q1 2023 | 19 | $48.4M |
| Q4 2022 | 20 | $61.0M |
| Q3 2022 | 22 | $47.8M |
| Q2 2022 | 29 | $45.7M |
| Q1 2022 | 43 | $146.8M |
| Q4 2021 | 35 | $181.8M |
| Q3 2021 | 32 | $310.7M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Climb Bio, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 13,150,849 | $39.7M | 1.06% | 00.0% | Unchanged |
| Silverarc Capital Management, LLC | 713,009 | $2.15M | 1.01% | +624,730+707.7% | Added |
| Woodline Partners LP | 373,368 | $1.13M | 0.02% | 00.0% | Unchanged |
| Vanguard Group Inc | 274,392 | $829.0K | 0.00% | −30,406−10.0% | Reduced |
| Goldman Sachs Group Inc | 162,792 | $492.0K | 0.00% | −2,295−1.4% | Reduced |
| Millennium Management LLC | 89,944 | $272.0K | 0.00% | +89,944 | New |
| Parkwood LLC | 67,202 | $203.0K | 0.04% | +26,069+63.4% | Added |
| Geode Capital Management, LLC | 64,139 | $193.0K | 0.00% | −48,882−43.3% | Reduced |
| BlackRock Inc. | 32,286 | $97.0K | 0.00% | −307,059−90.5% | Reduced |
| Tudor Investment Corp Et Al | 30,619 | $92.0K | 0.00% | −15,473−33.6% | Reduced |
| Ergoteles LLC | 26,364 | $80.0K | 0.00% | +26,364 | New |
| Atom Investors LP | 26,309 | $79.0K | 0.03% | +26,309 | New |
| Chicago Partners Investment Group LLC | 23,665 | $75.0K | 0.01% | +1,456+6.6% | Added |
| Bridgeway Capital Management, LLC | 20,423 | $62.0K | 0.00% | +2,023+11.0% | Added |
| State Street Corp | 19,800 | $60.0K | 0.00% | −75,270−79.2% | Reduced |
| Citadel Advisors LLC | 15,211 | $46.0K | 0.00% | +15,211 | New |
| Stifel Financial Corp | 12,830 | $39.0K | 0.00% | +2,673+26.3% | Added |
| Northern Trust Corp | 11,494 | $35.0K | 0.00% | −44,087−79.3% | Reduced |
| Morgan Stanley | 6,628 | $20.0K | 0.00% | +946+16.6% | Added |
| Bank of America Corp | 3,384 | $10.0K | 0.00% | +1,845+119.9% | Added |
| UBS Group AG | 2,282 | $7.00K | 0.00% | +666+41.2% | Added |
| Legal & General Group Plc | 560 | $2.00K | 0.00% | −99−15.0% | Reduced |
| Tower Research Capital LLC (TRC) | 440 | $1.00K | 0.00% | −1,991−81.9% | Reduced |
| Wells Fargo & Company | 44 | $0 | 0.00% | −3,674−98.8% | Reduced |
| New York State Common Retirement Fund | 59 | $0 | 0.00% | −3,300−98.2% | Reduced |
| Citigroup Inc | 53 | $0 | 0.00% | −371−87.5% | Reduced |
| Royal Bank of Canada | 28 | $0 | 0.00% | −342−92.4% | Reduced |
| FMR LLC | 9 | $0 | 0.00% | −85−90.4% | Reduced |
| Credit Suisse AG | 3 | $0 | 0.00% | +3 | New |
| Samlyn Capital, LLC | 0 | $0 | 0.00% | −2,130,237−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −227,201−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −142,333−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −16,001−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −15,874−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −13,893−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −3,841−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −2,995−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −2,829−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −2,850−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −2,593−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −2,400−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −1,600−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −1,039−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −541−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −638−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −170−100.0% | Sold out |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |